|
Tabla 3: Proporciones agrupadas de resistencia a los antibióticos para Escherichia coli. |
||||||
|
Resistencia % |
General N = 572 n (%) |
2020 N = 83 n (%) |
2021 N = 128 n (%) |
2022 N = 173 n (%) |
2023 N = 122 n (%) |
2024 N = 66 n (%) |
|
Ampicilina- sulbactam |
411 (71.9) |
61 (73.5) |
86 (67.2) |
126 (72.8) |
90 (73.8) |
48 (72.7) |
|
Ampicilina |
490 (85.7) |
71 (85.5) |
107 (83.6) |
148 (85.5) |
106 (86.9) |
58 (87.9) |
|
Amoxicilina- ácido clavulánico |
289 (50.5) |
37 (44.6) |
64 (50.0) |
94 (54.3) |
58 (47.5) |
36 (54.5) |
|
Ceftriaxona |
322 (56.3) |
47 (56.6) |
69 (53.9) |
100 (57.8) |
65 (53.3) |
41 (62.1) |
|
Cefotaxima |
381 (66.6) |
47 (56.6) |
74 (57.8) |
117 (67.6) |
100 (82.0) |
43 (65.2) |
|
Ciprofloxacino |
423 (74.0) |
54 (65.1) |
102 (79.7) |
128 (74.0) |
84 (68.9) |
55 (83.3) |
|
Gentamicina |
239 (41.8) |
34 (41.0) |
57 (44.5) |
81 (46.8) |
40 (32.8) |
27 (40.9) |
|
Levofloxacino |
568 (99.3) |
81 (97.6) |
128 (100.0) |
171 (98.8) |
122 (100.0) |
66 (100.0) |
|
Piperacilina- tazobactam |
362 (63.3) |
42 (50.6) |
80 (62.5) |
115 (66.5) |
78 (63.9) |
47 (71.2) |
|
Trimetoprima sulfametoxazol |
385 (67.3) |
55 (66.3) |
77 (60.2) |
118 (68.2) |
85 (69.7) |
50 (75.8) |
|
Amikacina |
254 (44.4) |
28 (33.7) |
70 (54.7) |
67 (38.7) |
60 (49.2) |
29 (43.9) |
|
Cefepima |
287 (50.2) |
28 (33.7) |
68 (53.1) |
79 (45.7) |
70 (57.4) |
42 (63.6) |
|
Cefuroxima |
291 (50.9) |
40 (48.2) |
68 (53.1) |
92 (53.2) |
62 (50.8) |
29 (43.9) |
|
Ertapenem |
29 (5.1) |
3 (3.6) |
5 (3.9) |
8 (4.6) |
7 (5.7) |
6 (9.1) |
|
Imipenem |
29 (5.1) |
1 (1.2) |
8 (6.3) |
7 (4.0) |
10 (8.2) |
3 (4.5) |
|
Meropenem |
27 (4.7) |
2 (2.4) |
4 (3.1) |
12 (6.9) |
8 (6.6) |
1 (1.5) |
|
Tetraciclina |
409 (71.5) |
62 (74.7) |
86 (67.2) |
141 (81.5) |
69 (56.6) |
51 (77.3) |
|
Tobramicina |
570 (99.7) |
82 (98.8) |
128 (100.0) |
173 (100.0) |
121 (99.2) |
66 (100.0) |
|
Ceftazidima |
258 (45.1) |
33 (39.8) |
37 (28.9) |
97 (56.1) |
52 (42.6) |
39 (59.1) |